JIGAR SIRROZI FONIDA KECHAYOTGAN GEPATOSELULAR RAKNING AKTUAL MULTIMODAL DIAGNOSTIKA USULLARI
;
Gepatotsellyulyar karsinoma; Ultratovush; kontrastli ultratovush; kompyuter tomografiyasi (KT); magnit-rezonans tomografiya (MRT); perfuzion tasvir.Abstrak
Gepatotsellyulyar karsinomani davolashda tasvirlashning roli sezilarli darajada rivojlandi va ko'p fazali kompyuter tomografiyasi (KT) yoki kontrastli magnit-rezonans tomografiya (MRT) bo'yicha odatiy naqshlarga asoslangan oddiy radiologik o'simtani tasdiqlashdan tashqari kengaydi. Gepatobiliar kontrast moddalarni joriy etish gepatokarsinogenezni oldingi bosqichlarda aniqlash imkonini berdi va ultratovush kontrastli vositalardan foydalanish diagnostika algoritmlarida ultratovushning rolini sezilarli darajada kuchaytirdi. KT va MRT ordamida qon perfuziyasini baholashning yangi miqdoriy usullari nafaqat erta tashxis qo'yish va boshqa lezyonlardan ishonchli farqlashni ta'minlaydi, balki davolanishga javobni baholash uchun biomarkerlarni ham beradi. Gepatosellular karsinomaning alohida subtiplari aniqlanganligi sababli, ularni o'ziga xos tasvirlash xususiyatlari bilan bog'lash o'smaning tajovuzkorligi va prognozini baholash uchun katta va'da beradi. Ushbu sharh gtpatosellular karsinoma bilan kasallangan bemorlarni muvaffaqiyatli boshqarishda uning ahamiyatini ta'kidlab, tasvirlashning hozirgi rolini ko'rsatadi.
Iqtiboslar
Marrero, J.A.; Kulik, L.M.; Sirlin, C.B.; Zhu, A.X.; Finn, R.S.; Abecassis, M.M.; Roberts, L.R.; Heimbach, J.K. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2018, 68, 723–750.
Galle, P.R.; Forner, A.; Llovet, J.M.; Mazzaferro, V.; Piscaglia, F.; Raoul, J.-L.; Schirmacher, P.; Vilgrain, V. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J. Hepatol. 2018, 69, 182–236.
Tanaka, H. Current role of ultrasound in the diagnosis of hepatocellular carcinoma. J. Med. Ultrason. 2020, 47, 239–255. Rodgers, S.K.; Fetzer, D.T.; Gabriel, H.; Seow, J.H.; Choi, H.H.; Maturen, K.E.; Wasnik, A.P.; Morgan, T.A.; Dahiya, N.; O’Boyle, M.K.; et al. Role of US LI-RADS in the LI-RADS Algorithm. RadioGraphics 2019, 39, 690–708.
Соринсон С.Н. Вирусные гепатиты в клинической практике. Изд. Теза. С-Петербург. 2015.
Delli Pizzi, A.; Mastrodicasa, D.; Cianci, R.; Serafini, F.L.; Mincuzzi, E.; Di Fabio, F.; Giammarino, A.; Mannetta, G.; Basilico, R.; Caulo, M. Multimodality Imaging of Hepatocellular Carcinoma: From Diagnosis to Treatment Response Assessment in Everyday Clinical Practice. Can. Assoc. Radiol. J. 2021, 72, 714–727.
Sangiovanni, A.; Del Ninno, E.; Fasani, P.; De Fazio, C.; Ronchi, G.; Romeo, R.; Morabito, A.; de Franchis, R.; Colombo, M. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004, 126, 1005–1014.
Акберов Р.Ф., Зогот С.Р., Ким А.Б. Комплексная клинико-лучевая диагностика холангио-целлюлярного рака // Врач-аспирант. 2011. № 5.1(48). С. 121-125.
Samoylova, M.L.; Mehta, N.; Roberts, J.P.; Yao, F.Y. Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma. Liver Transpl. 2018, 24, 1171–1177.
Makuuchi, M.; Hasegawa, H.; Yamazaki, S.; Bandai, Y.; Watanabe, G.; Ito, T. Ultrasonic characteristics of the small hepatocellular carcinoma. Ultrasound Med. Biol. 1983, (Suppl. S2), 489–491.
Minami, Y. Hepatic malignancies: Correlation between sonographic findings and pathological features. World J. Radiol. 2014, 2, 249.
Rimola, J.; Forner, A.; Tremosini, S.; Reig, M.; Vilana, R.; Bianchi, L.; Rodríguez-Lope, C.; Solé, M.; Ayuso, C.; Bruix, J. Non-invasive diagnosis of hepatocellular carcinoma ≤2cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI. J. Hepatol. 2016, 56, 1317–1323.
Таразов П.Г. Рентгеноэндоваскулярные вмешательства в лечении первичного рака печени // Практическая онкология. 2018. Т. 9, № 4. С. 209-215.
Semaan, S.; Vietti Violi, N.; Lewis, S.; Chatterji, M.; Song, C.; Besa, C.; Babb, J.S.; Fiel, M.I.; Schwartz, M.; Thung, S.; et al. Hepatocellular carcinoma detection in liver cirrhosis: Diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid. Eur. Radiol. 2020, 30, 1020–1030.
Hanna, R.F.; Miloushev, V.Z.; Tang, A.; Finklestone, L.A.; Brejt, S.Z.; Sandhu, R.S.; Santillan, C.S.; Wolfson, T.; Gamst, A.; Sirlin, C.B. Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma. Abdom. Radiol. 2016, 41, 71–90.
https://iris.who.int/bitstream/handle/10665/343841/9789289051958-rus.pdf?sequence=3&isAllowed=y
Ярошенко Е.Б., Буркевич Э.З., Майсюк Е.Г. Роль вирусных гепатитов в развитии гепато-целлюлярной карциномы // Практическая онкология. 2008. Т. 9, № 4. С. 189-194.
